Harness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.
Discover MoreNavigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.
Explore MedTech
Boost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.
Discover Innovations
Invest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.
Access InsightsUnlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.
Unlock Innovations
Accelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.
Navigate Health PlansLeverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.
Streamline Decisions
Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.
Uncover More
Embrace digital innovation in healthcare and transform your organization with a suite of cutting-edge registry solutions.
EXPLORE SOLUTIONS
Maximize your patient impact with expert guidance, data-driven insights, and a suite of cutting-edge patient data solutions.
DRIVE PATIENT IMPACTA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTS
"Collaborative Intelligence: Empowering the Human-AI Workforce in Life Sciences
REGISTER NOW
Stay ahead with a systematic approach to global health. This research outlines how to address challenges through concerted action and shared responsibility.
When the FDA needed to monitor COVID-19 vaccine safety across millions of Americans, traditional surveillance methods weren't fast enough. The CBER BEST Initiative required a partner who could analyze massive insurance claims data in near real-time to detect rare adverse events. IQVIA Government Solutions' surveillance system continuously monitored 17 adverse events among 15 million vaccinated individuals, providing critical safety insights to inform regulatory decisions.
The team implemented Poisson Maximized Sequential Probability Ratio Testing to compare observed versus expected outcome rates, enabling early detection of safety signals invisible in pre-licensure trials. Within months of vaccine rollout, the system identified elevated myocarditis/pericarditis rates in young men following mRNA vaccination.
This finding, published in The Lancet, represented one of the largest observational vaccine studies conducted at the time. By processing over 27 million vaccine doses across multiple insurance databases, IQVIA helped CBER make evidence-based regulatory decisions while vaccines were being administered nationwide. The surveillance system's ability to stratify risk by age, sex, and vaccine type allowed for targeted safety communications and informed clinical guidance, demonstrating how real-world data can enhance public health decision-making during critical moments.
